News Conference News TCT 2018 Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials Michael O'Riordan September 25, 2018
News Conference News TCT 2018 More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses Michael O'Riordan September 24, 2018
News Conference News TCT 2018 Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques Yael L. Maxwell September 24, 2018
News Conference News TCT 2018 OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients Todd Neale September 24, 2018
Presentation TCT 2018 EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Ajay J. Kirtane September 24, 2018
Presentation TCT 2018 GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Patrick W. Serruys September 24, 2018
Presentation TCT 2018 The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk Presenter: Dominick J. Angiolillo, Elmir Omerovic, Duk-Woo Park September 23, 2018
Presentation TCT 2018 De-Escalation of DAPT After DES Placement: Is There a Role for Personalized Treatment? Presenter: Dominick J. Angiolillo, Elmir Omerovic, Dániel Aradi September 23, 2018
Presentation TCT 2018 GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy Presenter: Dominick J. Angiolillo, Elmir Omerovic, Patrick W. Serruys September 23, 2018
Presentation TCT 2018 Managing Aspirin Allergy Before DES Placement Presenter: Dominick J. Angiolillo, Elmir Omerovic, John A. Bittl September 23, 2018
Presentation TCT 2018 Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy Presenter: George D. Dangas, Giuseppe Tarantini, Roxana Mehran September 23, 2018
Presentation TCT 2018 Case #2 Introduction: A Patient With Chronic CAD At High Bleeding Risk Requiring PCI Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia September 23, 2018
Presentation TCT 2018 Consensus: PCI Considerations In The High Bleeding Risk Patient With Chronic CAD Presenter: George D. Dangas, Giuseppe Tarantini September 23, 2018
Presentation TCT 2018 Utility of Cangrelor During PCI and Bridging Who Benefits Most? Presenter: John A. Bittl, C. Michael Gibson, Deepak L. Bhatt September 23, 2018
Presentation TCT 2018 How Strong are the Pharmacodynamic Data and Clinical Evidence for Crushed Ticagrelor and Prasugrel? Presenter: John A. Bittl, C. Michael Gibson, Dimitrios Alexopoulos September 23, 2018
Presentation TCT 2018 The Case for Bivalirudin With Radial (and Femoral) Access Presenter: John A. Bittl, C. Michael Gibson, Carey D. Kimmelstiel September 23, 2018
Presentation TCT 2018 Case #1 Introduction: A High Bleeding Risk Patient With Afib And ACS Requiring PCI And Oral Anticoagulant Therapy Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia September 23, 2018
Presentation TCT 2018 The Latest Antithrombotic Data: MATRIX at 1 Year Presenter: John A. Bittl, C. Michael Gibson, Stephan Windecker September 23, 2018
Presentation TCT 2018 Switching Dual Antiplatelet Therapy After PCI: Who, When, Why, and How? Presenter: John A. Bittl, C. Michael Gibson, Matthew J. Price September 23, 2018
Presentation TCT 2018 Benefits of Pretreatment With Dual Antiplatelet Therapy Prior to PCI in Stable CAD and ACS: Myth or Reality? Presenter: John A. Bittl, C. Michael Gibson, Giuseppe Tarantini September 23, 2018